Sanara Medtech Stock Today
| SMTI Stock | USD 34.69 0.34 0.99% |
PerformanceVery Weak
| Odds Of DistressLow
|
Sanara Medtech is trading at 34.69 as of the 2nd of March 2025. This is a 0.99 percent increase since the beginning of the trading day. The stock's open price was 34.35. Sanara Medtech has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 31st of January 2025 and ending today, the 2nd of March 2025. Click here to learn more.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. Sanara Medtech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 8.74 M outstanding shares of which 174.18 K shares are at this time shorted by private and institutional investors with about 7.25 trading days to cover. More on Sanara Medtech
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sanara Stock Highlights
Sanara Medtech (SMTI) is traded on NASDAQ Exchange in USA. It is located in 1200 Summit Avenue, Fort Worth, TX, United States, 76102 and employs 107 people. Sanara Medtech is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 303.23 M. Sanara Medtech conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 8.74 M outstanding shares of which 174.18 K shares are at this time shorted by private and institutional investors with about 7.25 trading days to cover.
Sanara Medtech currently holds about 12.68 M in cash with (3.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.53.
Check Sanara Medtech Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Sanara Medtech is $303.23 Million. Sanara Medtech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.45 % of Sanara Medtech outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Sanara Ownership Details
Sanara Medtech Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sanara Medtech market risk premium is the additional return an investor will receive from holding Sanara Medtech long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | 0.0409 | |||
| Treynor Ratio | (0.04) |
Sanara Stock Against Markets
Sanara Medtech Corporate Management
| Bill Fitzgerald | Compliance Officer | Profile | |
| Jacob Waldrop | Chief Officer | Profile | |
| Callon Nichols | Director Relations | Profile | |
| Elizabeth Taylor | Chief Officer | Profile | |
| Jane Fore | Chief Officer | Profile | |
| Tricia Matteson | Director Marketing | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.